Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Beyond Opioids: Drugs of Concern in Workers’ Compensation

As opioid utilization decreases, other pharmacy trends bear watching
Winter 2023/2024

Ask a Clinician: What Do I Need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME) trends
Winter 2023/2024

State of States

A roundup of regulatory activity around the country
Winter 2023/2024

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Approves a New Migraine Medication

Atzumi™ (dihydroergotamine (DHE)) nasal powder was approved for the treatment of acute migraine.
May 2025

Then and Now: 8 Reflections from 15 Years of RxInformer

In celebration of the 15 year anniversary of RxInformer, the editorial staff looked back at past issues to understand what has changed – and what hasn’t.
May 2025

WCRI Reports on the Impact of Marijuana Laws on Workers’ Comp Benefits

While recreational marijuana laws may be tied to increases in claim frequency, medical payments and prescriptions decreased, including those for opioids.
May 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.
May 2022

CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.
Jan 2022

Can Virtual Reality Help with Pain Management?

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.
Dec 2021
1 7 8 9 10 11 27

Whitepapers

lockmap-markermagnifiercrossmenucross-circle